Psoriatic arthritis trials in South Korea

5 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

  Where

  Seoul

  Age

  3 years to 64 years

  People

  196 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT06663332 · EU 2023-509560-16-00
• Phase 3Taking people
  A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines

  Where

  Seoul, Suwon

  Age

  18 years and over

  People

  1,088 worldwide

  Run by

  Takeda

  See details and how to joinNCT06671483 · EU 2024-513111-27-00
• No phaseTaking people
  Korean Post-marketing Surveillance for Xeljanz XR

  Where

  Seoul

  Age

  18 years and over

  People

  200

  Run by

  Pfizer

  See details and how to joinNCT04876781
• No phaseTaking people
  Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis

  Where

  Seoul

  Age

  2 years to 17 years

  People

  10

  Run by

  Pfizer

  See details and how to joinNCT05754710
• No phaseTaking people
  Korean College of Rheumatology Biologics and Targeted Therapy Registry

  Where

  Seoul

  Age

  18 years and over

  People

  10,000

  Run by

  Seoul National University Hospital

  See details and how to joinNCT01965132